Hormone therapy in endometrial cancer survivors: time for a change

Gynecol Endocrinol. 2022 Oct;38(10):795-796. doi: 10.1080/09513590.2022.2128105. Epub 2022 Sep 28.

Authors

Angelo Cagnacci^{1

2}, Ambrogio P Londero²

Affiliations

¹ Academic Unit of Obstetrics and Gynecology, IRCCS- San Martino Hospital of Genova, Genova, Italy.
² Department of Neurology, Rehabilitation, Ophthalmology, Genetics, Maternal and Infant Health (DiNOGMI), University of Genova, Genova, Italy.

PMID: 36170886
DOI: 10.1080/09513590.2022.2128105

No abstract available

Publication types

Editorial
Comment

MeSH terms

Cancer Survivors*
Endometrial Neoplasms*
Female
Hormones
Humans
Survivors

Substances

Hormones